Suchergebnisse
Recursion Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Recursion Pharmaceuticals, Inc.? Here are five stocks we like better.
- Recursion advanced its pipeline, moving its first neuroscience target from the Roche/Genentech
Roche Aktie: Kooperation mit ChemoMetec abgeschlossen
Roche stellt die Weichen für ein wachstumsstarkes zweites Halbjahr. Der Schweizer Gesundheitskonzern kombiniert operative…
Der Beitrag Roche Aktie: Kooperation mit ChemoMetec abgeschlossen erschien
OraSure Technologies Q2 Earnings Call Highlights
Key Points
- Interested in OraSure Technologies, Inc.? Here are five stocks we like better.
- Q2 revenue rose 9.7% sequentially to $30.6 million, exceeding guidance, as diagnostic-products revenue
Information Services Group Q2 Earnings Call Highlights
Key Points
- Interested in Information Services Group, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue rose 6.4% to $65.5 million and adjusted EBITDA
Tandem Diabetes Care Q2 Earnings Call Highlights
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Record second-quarter performance: Worldwide sales rose 6% year over year to $255 million, while pump
Lineage Cell Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better.
- Pipeline progress: Lineage advanced preclinical programs in corneal disease, Type 1 diabetes and
Seer Q2 Earnings Call Highlights
Key Points
- Interested in Seer, Inc.? Here are five stocks we like better.
- Seer’s second-quarter revenue fell year over year to $3.1 million from $4.1 million, pressured by academic and